Global Biomarker Technologies Market
Market Size in USD Billion
CAGR :
% 
 Forecast Period |
2022 –2029 |
 Market Size (Base Year) |
USD 32,203.40 Million |
 Market Size (Forecast Year) |
USD 93,487.04 Million |
 CAGR |
% |
| Major Markets Players |
|
Global Biomarker Technologies Market, By Product (Consumables, Instruments, Services, Software/Informatics), Profiling Technology (Chromatography, NGS, PCR, Mass Spectrometry, Immunoassay), Test Type (Liquid Biopsy, Solid Biopsy), Research Area (Genomics, Proteomics, Metabolomics, Other Research Areas), Application (Biomarker Identification, Validation and Development Research, Routine Biomarker-based Tests) – Industry Trends and Forecast to 2029
Market Analysis and Size
Patterns of gene expression are widely utilized to identify various diseases. Biomarkers are used in diagnosis of various diseases such as infectious diseases, cancer, autoimmune diseases, and others. The increase in prevalence of various diseases is rising the demand for biomarker technologies.
- Biomarkers are known to have the ability to diagnosis disease at early stage. Global biomarker technologies market was valued at USD 32,203.40 million in 2021 and is expected to reach USD 93,487.04 million by 2029, registering a CAGR of 14.25% during the forecast period of 2022-2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
Biomarker refers to a biological characteristic that is measured and evaluated as a maker of pathological processes or normal biological or a response to a therapeutic intervention. Biomarkers are widely utilized in diagnosis of various diseases, such as infectious diseases, cancer, and autoimmune diseases, among others.
|
Report Metric |
Details |
|
Forecast Period |
2022 to 2029 |
|
Base Year |
2021 |
|
Forecast Period |
2022 - 2029 |
|
Historic Years |
2020 (Customizable to 2019 - 2014) |
|
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
|
Segments Covered |
Product (Consumables, Instruments, Services, Software/Informatics), Profiling Technology (Chromatography, NGS, PCR, Mass Spectrometry, Immunoassay), Test Type (Liquid Biopsy, Solid Biopsy), Research Area (Genomics, Proteomics, Metabolomics, Other Research Areas), Application (Biomarker Identification, Validation and Development Research, Routine Biomarker-based Tests) |
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Market Players Covered |
Enzo Biochem Inc. (US), Bio-Rad Laboratories, Inc. (US), Merck KGaA (Germany), PerkinElmer Inc. (US), QIAGEN (Germany), Agilent Technologies, Inc. (US), Bruker (US), Epigenomics AG (Germany), MESO SCALE DIAGNOSTICS, LLC (US), EKF Diagnostics Holdings plc (UK), General Electric Company (US), Nexus-Dx (US), LifeSign LLC (US), F. Hoffmann-La Roche Ltd (Switzerland), among others |
Biomarker Technologies Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:
-
Funds and Grants
The surge in investments in the form of funds and grants for biomarker research accelerate the market growth.
-
Diagnostic Biomarker Technology
The inclination from conventional approach of pathophysiology/epidemiology to biomarker studies due to the technological advances further influence the market.
-
Prevalence of Cancer
The increase in the prevalence of cancer across the globe acts as one of the major factors driving the growth of biomarker technologies market.
Opportunities
Furthermore, increase in demand for personalized medicine extend profitable opportunities to the market players in the forecast period of 2022 to 2029. Also, continuous product innovation will further expand the market.
Restraints/Challenges
On the other hand, the high capital investments and lengthy timelines for biomarker development are expected to obstruct market growth. Also, technical issues related to sample collection and storage are projected to challenge the biomarker technologies market in the forecast period of 2022-2029.
This biomarker technologies market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on biomarker technologies market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Covid-19 Impact on Biomarker Technologies Market
Covid-19 had a positive impact on the biomarker technologies market. The increase in the number of COVID-19 accelerated the development of the biomarker technologies. Chinese research team pinpointed SARS-CoV-2 coronavirus infection from the molecular markers in the blood that are predictive of acute COVID-19. The biomarkers have become essential in clinical decision making for numerous infectious diseases treatment procedures.
Recent Development
- F. Hoffmann-La Roche Ltd. launched two cardiac biomarker tests for N-terminal pro-brain natriuretic peptide test (NT-proBNP) and high sensitive cardiac troponin T (cTnT-hs) in April’2021. The cardiac biomarkers assist clinicians in diagnosing heart attacks and manage heart failure better.
- QIAGEN N.V. (Netherlands) launched first FDA-approved tissue companion diagnostic, therascreen KRAS RGQ PCR Kit in May’2021. The diagnostics will identify the KRAS G12C mutation in NSCLC tumors and expand precision medicine options.
Global Biomarker Technologies Market Scope and Market Size
The biomarker technologies market is segmented on the basis of product, profiling technology, test type, research area and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Consumables
- Instruments
- Services
- Software/Informatics
On the basis of product, the biomarker technologies market is segmented into consumables, instruments, services, and software/informatics.
Profiling Technology
- Chromatography
- NGS
- PCR
- Mass Spectrometry
- Immunoassay
On the basis of profiling technology, the biomarker technologies market is segmented into chromatography, NGS, PCR, mass spectrometry, immunoassay. Immunoassay is further sub segmented into ELISA, western blot and protein microarray.
Test Type
- Liquid Biopsy
- Solid Biopsy
On the basis of test type, the biomarker technologies market is segmented into liquid biopsy and solid biopsy. Liquid biopsy is further sub segmented into ddPCR, NGS, mass spectrometry, DHPLC and other technologies.
Research Area
- Genomics
- Proteomics
- Metabolomics
- Other Research Areas
On the basis of research area, the biomarker technologies market is segmented into genomics, proteomics, metabolomics, and other research areas. Metabolomics is further sub segmented into metabolic flux, lipidomics and others.
Application
- Biomarker Identification
- Validation and Development Research
- Routine Biomarker-Based Tests
On the basis of application, the biomarker technologies market is segmented into biomarker identification, validation and development research, routine biomarker-based tests.
Biomarker Technologies Market Regional Analysis/Insights
The biomarker technologies market is analysed and market size insights and trends are provided by country, product, profiling technology, test type, research area and application as referenced above.
The countries covered in the biomarker technologies market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the biomarker technologies market because of the rise in geriatric population, and support from private and public organizations within the region.
Asia-Pacific (APAC) is expected to witness significant growth during the forecast period of 2022 to 2029 due to the rise in awareness related to early screening of cancer for better treatment in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The biomarker technologies market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for biomarker technologies market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the biomarker technologies market. The data is available for historic period 2010-2020.
Competitive Landscape and Biomarker Technologies Market Share Analysis
The biomarker technologies market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to biomarker technologies market.
Some of the major players operating in the biomarker technologies market are Enzo Biochem Inc. (US), Bio-Rad Laboratories, Inc. (US), Merck KGaA (Germany), PerkinElmer Inc. (US), QIAGEN (Germany), Agilent Technologies, Inc. (US), Bruker (US), Epigenomics AG (Germany), MESO SCALE DIAGNOSTICS, LLC (US), EKF Diagnostics Holdings plc (UK), General Electric Company (US), Nexus-Dx (US), LifeSign LLC (US), F. Hoffmann-La Roche Ltd (Switzerland), among others.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
